key: cord-0035230-b9jtiqim authors: Tramper, Johannes; Zhu, Yang title: Xenotransplantation date: 2011 journal: Modern Biotechnology DOI: 10.3920/978-90-8686-725-7_12 sha: 52b74e2f1d2a462fc5f1a0d3c6adabd13bd6a48d doc_id: 35230 cord_uid: b9jtiqim The above statement was made by Guido Persijn, former Medical Director of the Eurotransplant Foundation, an international organisation that coordinates organ donation and transplantation. Xenotransplantation is the transplantation of organs, tissues or cells from one species of animal to another. This chapter will look at transplantations between animal and humans. Xenotransplantation is one possible solution for the organ donor shortage in the area of transplant medicine(77). However, there is still a ban on this type of procedure because of the lack of clarity about the sort of risks entailed. The natural rejection responses to cross–species components still create insurmountable problems. The transfer of viral DNA with, as yet, unpredictable consequences is also another matter that requires due attention. The various facets of this topic will be discussed in this chapter, as will the question of whether or not xenotransplantation is ethically responsible. We’ll begin with the history of xenotransplantation, which has its origins in a dark past. clearly show is that the idea of extending or enhancing life, by replacing failing or missing organs with organs from a human donor, was already around a long time ago. The first xenotransplantations were carried out at the beginning of the sixteenth century with cells and tissues from bone, skin, and testicles, etc., the latter playing a particularly important role (Textbox 12.2). Organs were only used much later on, because for a long time there was no technique to keep the bleeding under control once the diseased organ had been cut out, and no way to restore blood circulation after the transplant. In 1668 the Dutchman Job van Meekeren reported a successful xenotransplantation with bone, performed by a Russian who used a piece of dog skull to repair a human skull. His claim that this had never been done before was later refuted. In 1501 the Iranian physician The Quintessence of Experience. In it he described the surgical removal of a piece of skull that was infected and replaced by a piece of dog bone, the brain being protected by a piece of cucumber. He also reported that in Herat, Afghanistan, the Indian surgeon Ala-ul-Din had used fresh canine skin to replace all the skin on the head of a patient suffering from eczema. These (Prather, 2007) . Sykes (Yang & Sykes, 2007a , 2007b in two leading journals. These data are not easy to summarise, but suffice it to say, there is still a long way to go. On the website 78 of Cytos Biotechnology we found a short and simple summary of the immune system (Textbox is developing and commercialising a novel class of medicines -called Immunodrugs™. Immunodrugs™ are therapeutic vaccines intended for use in the treatment and prevention of common chronic diseases which afflict millions of people worldwide. TEXTBOX 12.3. The immune system -some basic facts. So to start with, a successful xenotransplantation involves preventing hyperacute rejection (Reaction 1). The most obvious solution is to give the pig the sugar chain that corresponds to the determinant of our blood group 'O', because there are no antibodies for this sugar chain (Reaction 2). This means that only the extremity of the sugar chain, the galactose α-1,3-galactose epitope (an epitope is the location on the antigen which can be specifically recognised by antibodies that will bind to it) in the blood group determinant of the pig, will have to be changed: a fucose in place of a galactose. The enzyme that links the latter sugar unit (galactose), Biotherapeutics to make an α-1,3-GalT knock-out of the Imutran pigs with an hDAF gene (Prather, 2007) . (Schuurman, 2008) . One reason for this is that less than five percent of the islets of Langerhans in pigs have the Gal epitope, meaning that the risk of hyperacute rejection is smaller than in other pig organs (Prather, 2007) . Consequently, no α-1,3-GalT knock-out pigs are expected to be needed, in contrast to other pig organs. Rajotte (2008) states that, according to clinical research, the preparation and transplantation of the islets must be SAS -Safe, Affordable and Simple: (1) safe with regard to the transfer of pathogens (see following section), (2) In short, there's still a long way to go just with regard to facilities and protocols. The biggest concern is about the pig endogenous retrovirus (PERV), of which there are several copies in the pig genome. This concern goes back to 1997 when it was shown that PERV could infect human cells In 1998 about two and a half million Dutch people registered their organs for transplant after their death. However, this generous gesture is a drop in the ocean. Compared with other forms of organ replacement (existing and experimental), xenotransplantation was found to be the least acceptable. Many believed that xenotransplantation should only be allowed if there were no other ways of solving the donor shortage problem. The risk of infection was the most important concern, but for the majority of people this was not a defining enough reason to reject xenotransplantation. In any case, people didn't expect xenotransplantation to be used as long as there were still uncertainties about the risks. Opponents objected to the consequences for animals with regard to animal welfare, genetic modification and the fact that xenotransplantation is a new use of animals. Others found these consequences problematic too, but for them the purpose of the use (saving human lives) was more important. Nor did the latter group see any basic difference between this and using animals for other purposes, such as eating them. Young people were much more concerned about surviving than adults. While adults were more inclined to accept the end of their lives, young people were more willing to calculate in certain downsides of xenotransplantation. In conclusion, we would like to mention that people also indicated the desire to be able to vote in the future as to whether or not xenotransplantation goes ahead. Crucial in this regard was clarity on the criteria used by the government and doctors when deciding on who gets which treatment. That, then, was the final report on the public debate. A Dutch website that is constantly concerned with this theme is that of the working group on transplantation questions, which critically analyses all the medical, moral and risk aspects of transplantation 85 . There is also a lot of relevant information to be found abroad, for example, from Canadian supporters 86 and American 87 and British 88 opponents. Little has happened in the Netherlands since the big debate. Xenotransplantation has received very little attention and not much has changed as regards the thorny points. The global picture is very similar. What we do see is that there are still many scientific publications and review articles appearing. George In recent reviews, Professor Mariachiara Tallacchini (Tallacchini, 2008; Tallacchini & Beloucif, 2009) defines what she sees as a suitable ethical, social and regulatory framework for clinical xenotransplantation. She does so on the basis of an analysis of recent literature on regulatory questions concerning xenotransplantation. She concludes that the global scale on which the research is currently taking place, requires that some aspects of xenotransplantation should be reconsidered. can, in her opinion, not only have undesirable local effects, but international implications as well. Conversely, the lack of international implementation of rules or "loose" interpretation of standards has a negative impact on groups and populations who are already disadvantaged, and may result in potential risks worldwide. Although specific subjects such as animal welfare and rights continue to be discussed, the most important aspect of the regulatory questions concerning xenotransplantation is increasingly shifting to the multi-faceted aspects of locality and globality, where space, as well as formal legislation, is created for non-governmental networks as potentially flexible and normative instruments. In short, if we the authors understand it correctly, there's still a long way to go. So far, the religious angle has received little attention in the press and scientific literature. We have only been able to find one recent article on this (Bruzzone, It's not always possible to rationalise. It is fortunate that the decision rests not only on scientists' shoulders, but also on those of the whole of society. Companies are also wrestling with this problem. Geron Bio-Med in Roslin, Scotland, a company trying in various ways to apply the cloning technique used to "make" Dolly the Sheep and to make money out of it, reported in mid-2000 that it was getting rid of its potential donor pigs. The company was planning to focus on embryonic stem cells that can be converted in the laboratory into specialised human cells and tissues for all sorts of medical applications (Chapter 14). The hope is that whole organs can be made in this way. Human, not animal, organs -from our own stem cells. But that's still in the future. In an interview in 2005, leading stem cell researcher Christine Mummery said that she wouldn't bet all her money on stem cell research being successful in this area. "If you need whole organs, xenotransplantation will be the only option for a long time to come", she predicted. Yang and Sykes (Yang & Sykes, 2007b) This chapter has demonstrated that xenotransplantation is still a tricky business, both technically and ethically. The technical problems around rejection can probably be overcome in the relatively short term, but we certainly haven't read or heard the last word on the ethics and the risk of new viruses. Only when the most serious rejection hurdles and viral risks have been eliminated, can the practice really show whether complete pig organs can fulfil their replacement function as desired, or whether they will simply act as a short-term transition for the transplantation of human organs. This will obviously vary according to the organ in question: the heart has a less complex biochemical interaction with the body than the kidneys or liver. But this doesn't detract from the fact that more research is definitely needed in the area of xenotransplantation, however much the opinions of opponents and proponents differ. Maybe other options, such as organ breeding using stem cells, will catch up with the "spare pig parts" possibility before it comes into practice. This is surely more likely now that we have come to the end of the Bush era, when ethical considerations got in the way of federal financing for most research involving human embryonic stem cells. With the arrival of President Obama, change is in the air. Than again, maybe the xenotransplantation cynics will be right after all: "Xenotransplantation is the future and always will be." Only time will tell if they are right. TEXTBOX 12.5. Willem Johan Kolff (1911 Kolff ( -2009 Transgenic pigs for xenotransplantation: selection of promoter sequences for reliable transgene expression. Current Opinion in Organ Transplantation Religious aspects of organ transplantation Xenotransplantation: The next generation of engineered animals History of xenotransplantation Xenotransplantation: an ethical dilemma Genetic modification of pigs as organ donors for xenotransplantation Reappraisal of biosafety risks posed by PERVs in xenotransplantation The rationale and practical issues for the maintenance of clean herds for clinical islet xenotransplantation Current status of xenotransplantation and prospects for clinical application Targeted genetic modification: Xenotransplantation and beyond Moving towards clinical application Regulatory aspects of pig-to-human islet transplantation Het complementsysteem en de klinische gevolgen van stoornissen Xenotransplantation: where are we in Defining an appropriate ethical, social and regulatory framework for clinical xenotransplantation. Current Opinion in Organ Transplantation Regulatory issues in xenotransplantation: recent developments. Current Opinion in Organ Transplantation Varkentje vol reserveonderdelen. Chemisch Magazine Tolerance in xenotransplantation. Current Opinion in Xenotransplantation: current status and a perspective on the future